K.C. Balaji, MD
Chief of Urology, W.G. (Bill) Hefner VA Medical Center, Salisbury, North Carolina
Professor of Urology and Cancer Biology, Wake Forest University School of Medicine, Winston Salem, North Carolina
Department of Urology, Cancer Biology, Institute of Regenerative Medicine
Wake Forest University School of Medicine, W.G. (Bill) Hefner VA Medical CenterTable of Contents
"Castration Resistant Prostate Cancer"
Editors: K.C Balaji
Ch. 1: Introduction
K.C Balaji
Ch. 2: Pathophysiology of Castration-Resistant Prostate Cancer
Justin C. PenticuffNatasha Kyprianou
Ch. 3: Androgen Receptor Signaling in Castration Resistant Prostate Cancer
Yu Zhao
Donald J. TindallHaojie Huang
Ch. 4: Non-Androgen Signaling Pathways in Castration-Resistant Prostate Cancer
Sivanandane Sittadjody
Thilakavathy Thangasamy
Bita NickKolgh
K.C. Balaji
Ch. 5: Predictive Models in Castration Resistant Prostate Cancer
Tao Cui
Michael W. Kattan
Ch. 6: Docetaxel in Advanced and Castration Resistant Prostate Cancer
Daniel P. PetrylakNavid Hafez
Ch. 7: Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate
Ben Fulton
Robert J. Jones
Ch. 8: Cancer Vaccines in Castration Resistant Prostate Cancer - An evolution in design
Susan F. Slovin
Ch. 9: Abiraterone for the treatment of mCRPC
Zafeiris Zafeiriou
Niven Mehra
Johann S. de Bono
Ch. 10: Enzalutamide in Metastatic Castration Resistant Prostate Cancer
Jeffrey Shevach
Bridget K. Marcellino
William K. Oh
Che-Kai Tsao
Ch. 11: Radium-223 in Metastatic Castrate Resistant Prostate Cancer
Tu Dan
Robert B. Den
Ch. 12: Cabazitaxel for the Treatment of Prostate Cancer
Michael Kolinsky
Niven Mehra
Johann S. de Bono
Ch. 13: Sequencing Therapies in Metastatic Castration Resistant Prostate Cancer
Michael T. Schweizer
Bruce Montgomery
Ch. 14: Bone Preservation Strategies for Men on Androgen Deprivation Therapy
Charles C. Peyton
K. C. Balaji
Ch. 15: Novel Therapies in Castration-Resistant Prostate Cancer
Tyler Lash
Rhonda L. Bitting